AI is increasingly being leveraged to address challenges in breast cancer care, from a “second set of eyes” during screening to enabling more personalised treatments. Innovators...
A new MRI breast screening trial aims to find cancers missed by mammograms in women with average breast density. The Fast MRI Dyamond study will involve...
Lobular breast cancer affects 15 per cent of patients but rarely forms lumps, meaning symptoms are often missed or misdiagnosed until later stages, experts have warned....
A new ovarian cancer drug has been approved in the UK for patients whose tumours no longer respond to platinum-based chemotherapy. The Medicines and Healthcare products...
A new device could detect a key endometriosis biomarker in menstrual blood within 10 minutes, researchers have found. The test identifies HMGB1 – a protein linked...
Eight tech startups have joined an accelerator programme developing tools to tackle women’s cardiovascular and brain health conditions. The firms have been selected for the American...
More than 30 MPs have urged the health secretary to act over DES, a pregnancy drug linked to cancer and fertility problems in children exposed in...
Around 5,700 breast cancer patients will now be eligible for ribociclib after NICE widened access to the combination therapy. Ribociclib will be available on the NHS...
Targeted radiotherapy is as effective as full-breast treatment for low-risk breast cancer but causes fewer side effects, a decade-long UK study has found. Partial-breast radiotherapy, which...
Mounjaro may significantly reduce breast cancer tumour growth in obese patients, according to early-stage research in mice. The weight loss drug, which contains tirzepatide, showed what...
